Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Sargramostim (DB00020)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00501644Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerTreatment